Literature DB >> 11208115

Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones.

A Gruhler1, K Früh.   

Abstract

MHC class I molecules assemble with peptides in the endoplasmic reticulum (ER). To ensure that only peptide-loaded MHC molecules leave the ER, empty molecules are retained by ER-resident chaperones, most notably the MHC-specific tapasin. ER exit of class I MHC is also controlled by viruses, but for the opposite purpose of preventing peptide presentation to T cells. Interestingly, some viral proteins are able to retain MHC class I molecules in the ER despite being transported. By contrast, other viral proteins exit the ER only upon binding to class I MHC, thereby rerouting newly synthesized class I molecules to intracellular sites of proteolysis. Thus, immune escape can be achieved by reversing, inhibiting or redirecting the chaperone-assisted MHC class I folding, assembly and intracellular transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208115     DOI: 10.1034/j.1600-0854.2000.010403.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  9 in total

1.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Characterization of the rhesus cytomegalovirus US28 locus.

Authors:  M E T Penfold; T L Schmidt; D J Dairaghi; P A Barry; T J Schall
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

3.  Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.

Authors:  Zhiguo Sun; Hem Chandra Jha; Yong-Gang Pei; Erle S Robertson
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling.

Authors:  A Fraile-Ramos; T N Kledal; A Pelchen-Matthews; K Bowers; T W Schwartz; M Marsh
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

5.  Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.

Authors:  Nagendra R Hegde; Roman A Tomazin; Todd W Wisner; Claire Dunn; Jessica M Boname; David M Lewinsohn; David C Johnson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.

Authors:  A B Del Campo; J Carretero; J A Muñoz; S Zinchenko; F Ruiz-Cabello; G González-Aseguinolaza; F Garrido; N Aptsiauri
Journal:  Cancer Gene Ther       Date:  2014-06-27       Impact factor: 5.987

7.  A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation.

Authors:  Srikant Rangaraju; Syed Ali Raza; Andrea Pennati; Qiudong Deng; Eric B Dammer; Duc Duong; Michael W Pennington; Malu G Tansey; James J Lah; Ranjita Betarbet; Nicholas T Seyfried; Allan I Levey
Journal:  J Neuroinflammation       Date:  2017-06-26       Impact factor: 8.322

8.  Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.

Authors:  Colin J Powers; Klaus Früh
Journal:  PLoS Pathog       Date:  2008-10-03       Impact factor: 6.823

9.  Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development.

Authors:  Jinxia Ma; Stefanie Trop; Samantha Baer; Elian Rakhmanaliev; Zita Arany; Peter Dumoulin; Hao Zhang; Julia Romano; Isabelle Coppens; Victor Levitsky; Jelena Levitskaya
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.